Page 19 - Biorefinery 2030 Future Prospects for the Bioeconomy (2015)
P. 19

xviii                                                       Contents


                  3.2  What Are the Strengths, Weaknesses, Opportunities and Threats
                      for the Bazancourt-Pomacle Biorefinery? . . . . . . . . . . . . . . . .  59
                  3.3  BIOAMBER: A Locally Unrecognised Success Story .......  62
               References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  65
            3  Industrial Symbiosis at the Bazancourt-Pomacle Biorefinery . .... .  67
               1  What Is Industrial Symbiosis? . . . . . . .... ... .... ... .... ... .  68
               2  Different Aspects of Industrial Symbiosis at the
                  Bazancourt-Pomacle Biorefinery . . . . . . . . . . . . . . . . . . . . . . . . . .  70
                  2.1  The Bazancourt-Pomacle Biorefinery and Its Local
                      Environment ............. ........................    71
                  2.2  The Firms Making Up the Biorefinery . .... .............  72
                  2.3  The Biorefinery and Water Symbiosis . . . ........ .......  74
                  2.4  Possible Improvements to the System . . . . . . . . .... ... ...  78
               References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  80
            4  Prospects for the Bazancourt-Pomacle Biorefinery Between
               Now and 2030 ... .. ... .. ... ... .. ... .. ... .. ... ... .. ... .. .  81
               1  Challenges for the White Biotechnology Centre
                  of Excellence (CEBB) . . . . . . . . . . . . . . . . . . . . . . . . .... ... ...  83
                  1.1  Multidisciplinarity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  84
                  1.2  The Public-Private Partnership .... ......... ......... ..  85
                  1.3  Governance ............................. ........    85
               2  Recent Developments: 2014, a Turning Point? . . . . . .... ... ... .  86
                  2.1  The Sale by ARD of Its Subsidiary SOLIANCE
                      to the GIVAUDAN Group ........ ................. ..   86
                  2.2  ARD’s BIODEMO Demonstrator . . . . . . . . . . . . . . . . . . . . .  87
                  2.3  The FUTUROL Industrial Pilot Scheme . . .... ... .... ... .  88
               3  Potential for Integration of the Upstream Value Chain .... ......  89
                  3.1  The Idea of an Experimental Farm . . . . . . . . . . . . . . . . . . . . .  90
                  3.2  Upstream Industry . ..... ..... ..... ..... ..... ..... .  91
                  3.3  Cumulative Effects? . .... ... .... ... .... .... ... .... .  91
               4  Potential for Integration with the Downstream Value Chain . . .....  92
                  4.1  Land Available for New Manufacturing Facilities
                      or Biorefineries . . .... ... ... ... .... ... ... ... .... ...  92
                  4.2  Downstream Industry . . . . . .... ... .... ... .... ... ....  93
                  4.3  The Move Downstream by Industrials and Cooperatives . . . . .  94
               5  Maintaining or Renewing the Virtues of the Cooperative Model . . . .  95
                  5.1  The Period 2015–2030–2040 .... .......... ......... ..  95
                  5.2  The Basis of the Cooperative Model . . . . . . . . . . . . . . . . . . .  96
                  5.3  Is It Possible to Benefit from Cooperative Values Without
                      Cooperatives? . . . . . .... ... ... .... ... .... ... ... ....  97
               6  Does the IEB Need a More Formal Governance Structure? . ..... .  97
                  6.1  Networking, Strategic Monitoring and Strategic
                      Decision-Making Tools . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  98
   14   15   16   17   18   19   20   21   22   23   24